Announcements Trials
Browse Landscape

Status

Completed 58Recruiting 28Unknown 27Not yet recruiting 13Terminated 11Withdrawn 8Active not recruiting 7Enrolling by invitation 2No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1

Conditions

Neoplasms 73Breast Neoplasms 70Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 25Stomach Neoplasms 20Carcinoma, Hepatocellular 20Uterine Cervical Neoplasms 19Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Brain Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 11Esophageal Neoplasms 10Diabetes Mellitus 10Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Sarcoma 8Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Multiple Myeloma 8Esophageal Squamous Cell Carcinoma 8Disease 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Disease Progression × Clear all
NCT02270567 2025-11-13

RegisterNET

Wren Laboratories LLC

Enrolling by invitation
400 enrolled
EndocrineNET

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Disease Progression

NCT06962449 2025-05-08

REALM-Post

Shanghai Chest Hospital

Enrolling by invitation
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡